426 related articles for article (PubMed ID: 18790132)
1. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
Dillon R; Greig MJ; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
[TBL] [Abstract][Full Text] [Related]
2. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
3. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells.
Choi Y; Park Y; Pariza MW; Ntambi JM
Biochem Biophys Res Commun; 2001 Jun; 284(3):689-93. PubMed ID: 11396956
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
6. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
7. [Stearoyl-CoA desaturase in the control of metabolic homeostasis].
Dobrzyń P
Postepy Biochem; 2012; 58(2):166-74. PubMed ID: 23214140
[TBL] [Abstract][Full Text] [Related]
8. A model cell line to study regulation of stearoyl-CoA desaturase gene 1 expression by insulin and polyunsaturated fatty acids.
Ntambi JM; Sessler AM; Takova T
Biochem Biophys Res Commun; 1996 Mar; 220(3):990-5. PubMed ID: 8607881
[TBL] [Abstract][Full Text] [Related]
9. Key role of the ERK1/2 MAPK pathway in the transcriptional regulation of the Stearoyl-CoA Desaturase (SCD1) gene expression in response to leptin.
Mauvoisin D; Prévost M; Ducheix S; Arnaud MP; Mounier C
Mol Cell Endocrinol; 2010 May; 319(1-2):116-28. PubMed ID: 20109524
[TBL] [Abstract][Full Text] [Related]
10. A novel assay of cellular stearoyl-CoA desaturase activity of primary rat hepatocytes by HPLC.
Su C; Gullberg H; Simko H; Luthman M; Edlund PO; Lundbäck T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(26):2427-32. PubMed ID: 20732836
[TBL] [Abstract][Full Text] [Related]
11. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
[TBL] [Abstract][Full Text] [Related]
12. Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.
Zhang Z; Sun S; Kodumuru V; Hou D; Liu S; Chakka N; Sviridov S; Chowdhury S; McLaren DG; Ratkay LG; Khakh K; Cheng X; Gschwend HW; Kamboj R; Fu J; Winther MD
J Med Chem; 2013 Jan; 56(2):568-83. PubMed ID: 23245208
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of stearoyl-CoA desaturase-1 in differentiating 3T3-L1 preadipocytes upregulates elongase 6 and downregulates genes affecting triacylglycerol synthesis.
Ralston JC; Badoud F; Cattrysse B; McNicholas PD; Mutch DM
Int J Obes (Lond); 2014 Nov; 38(11):1449-56. PubMed ID: 24566853
[TBL] [Abstract][Full Text] [Related]
14. Stearoyl-CoA desaturase inhibitors: update on patented compounds.
Liu G
Expert Opin Ther Pat; 2009 Sep; 19(9):1169-91. PubMed ID: 19691439
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
[TBL] [Abstract][Full Text] [Related]
16. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
17. SCD1 inhibition during 3T3-L1 adipocyte differentiation remodels triacylglycerol, diacylglycerol and phospholipid fatty acid composition.
Ralston JC; Mutch DM
Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():29-37. PubMed ID: 25959085
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors.
Zhao H; Serby MD; Smith HT; Cao N; Suhar TS; Surowy TK; Camp HS; Collins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2007 Jun; 17(12):3388-91. PubMed ID: 17434733
[TBL] [Abstract][Full Text] [Related]
19. Hormonal and nutritional regulation of SCD1 gene expression.
Mauvoisin D; Mounier C
Biochimie; 2011 Jan; 93(1):78-86. PubMed ID: 20713121
[TBL] [Abstract][Full Text] [Related]
20. Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin.
Zheng Y; Prouty SM; Harmon A; Sundberg JP; Stenn KS; Parimoo S
Genomics; 2001 Jan; 71(2):182-91. PubMed ID: 11161812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
